Debating human genetics: Contemporary issues in public policy and ethics

Debating Human Genetics: Contemporary Issues in Public Policy and Ethics

Volumn , Issue , 2010, Pages 1-232

  Plows, Alexandra ^a  

^a BANGOR UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84917242778     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203926925     Document Type: Book

References (490)

1. ACOEM (2005)Genetic Screening in the Workplace, Elk Grove: ACOEM.
2. ACOEM (2005)DNA good practice manual, London: ACPO.
3. African Ancestry (2009a)African Ancestry benefits are unparalleled, brochure.
4. African Ancestry (2009b) Discover the Paternal Roots of Your Family Tree Brochure.
5. Ahteensuu, M. (2004) ‘The Precautionary Principle in the Risk Management of Modern Biotechnology’, Science Studies17: 57-65.
6. Ainger, K., Chesters, G., Credland, A. et al. (eds) (2003)We Are Everywhere, London: Verso.
7. Aldred, M.J., Crawford, P.J.M., Savarirayan, R. et al. (2003) ‘It’s only teeth - are there limits to genetic testing?’Clinical Genetics63 (5): 333-9.
8. Alexander, A. (2006a) ‘Clinical drug trials - leading clinical negligence solicitor explains’, Alexander Harris press release 23 March 2006.
9. Alexander, A. (2006b) ‘Too much secrecy, too many questions left unanswered’ Alexander Harris press release, 6 April 2006.
10. Alexander, A. (2006c) ‘Specialist drugs trial solicitor criticises MHRA report into failed drugs trial’ Alexander Harris press release 25 May 2006.
11. Altmann, J. (2004) ‘Military uses of nanotechnology: perspectives and concerns’, Security Dialogue35 (1): 61-79.
12. AMRC (2003) ‘AMRC statement on human embryo and stem cell research’, AMRC press release May 2003.
13. Anderson, I. et al (eds) (2007)Beyond Bandaids: Exploring the Underlying Social Determinants of Aboriginal Health ‘Papers from the Social Determinants of Aboriginal Health Workshop, Adelaide, July 2004’, Casuarina: CRCAH.
14. Angell, M. (2005)The Truth About Drug Companies: How they deceive us and what to do about it, New York: Random House.
15. AP (2005) ‘“Stem cell therapy” craze spreads in Russia: Despite warnings, clinics and beauty salons offer treatments’, Associated Press 14 March 2005.
16. APDB (2007) Australian Plant DNA Bank Ltd Annual Report, Lismore: APDB.
17. Ashcroft, A.E. (2009) An Introduction to Mass Spectrometry (Handout) University of Leeds.
18. Barry, J. (2005) ‘Resistance is Fertile: from environmental to sustainability citizenship’, in Bell, D.and Dobson, A. (eds) Environment and Citizenship, Cambridge, MA: MIT Press.
19. Batt, S. (1994)Patient No More: the politics of breast cancer, London: Scarlet Press.
20. Bauer, M. (ed.) (1995)Resistance to New Technology: Nuclear Power, Information technology and Biotechnology, Cambridge: Cambridge University Press.
21. Bauer, M. and Gaskell, G. (eds) (2003)Biotechnology: The Makings of a Global Controversy, Cambridge: Cambridge University Press.
22. BBC (2001) ‘Cleft palate gene found’, BBC News 16 September 2001.
23. BBC (2004a) ‘Cloning milestones’, BBC News 12 February 2004.
24. BBC (2004b) ‘“Designer babies”: Relax the rules?’, BBC News 23 July 2004.
25. BBC (2006a) ‘Call for inquiry into DNA samples’, BBC News 5 January 2006.
26. BBC (2006b) ‘Juveniles’ DNA recording defended’, BBC News 21 January 2006.
27. BBC (2006c) ‘Zimbabweans have “shortest lives”’, BBC News 8 April 2006.
28. BBC (2006d) ‘DNA database has 50,000 children’, BBC News 17 May 2006.
29. BBC (2007) ‘Bowel cancer risk gene pinpointed’, BBC News 8 July 2007.
30. BBC (2008a) ‘Synthetic life “advance” reported’, BBC News 24 January 2008.
31. BBC (2008b) ‘Obesity gene “affects appetite”’, BBC News 27 July 2008.
32. BBC (2008c) ‘Tories warn of obesity “excuses”’, BBC News 27 August 2008.
33. BBC (2008d) ‘Windpipe transplant breakthrough’, BBC News 19 November 2008.
34. BBC (2008e) ‘Gene “triggers unhealthy eating”’, BBC News 11 December 2008.
35. BBSRC (2008) ‘Public-private research partnership announces £4M of projects to improve UK diet and health’, BBSRC press release, 8 August 2008.
36. Beck, U. (1992)Risk society; towards a new modernity, London: Sage Publications.
37. Beck, U. (1995)Ecological Politics in an Age of Risk, Cambridge: Polity Press.
38. Bender, W., Hauskeller, C. and Manzei, A. (eds) (2005)Crossing Borders: Cultural, Religious and Political Differences Concerning Stem Cell Research, Münster: Agenda Verlag.
39. Bharadwaj, A. (2005) ‘Cultures of embryonic stem cell research in India’ in Bender, W. et al. (eds) Crossing Borders: Cultural, Religious and Political Differences Concerning Stem Cell Research, Münster: Agenda Verlag.
40. Bijker, W.E. (1987) ‘The social construction of bakelite: towards a theory of invention’, in Bijker, W.E., Hughes, T.P. and Pinch, T.J. (eds) The Social Construction of Technological Systems: New Directions in the Sociology and History of Technology, Cambridge, MA: MIT Press.
41. Birch, K. (2006) ‘The neoliberal underpinnings of the bioeconomy: the ideological discourses and practices of economic competitiveness’, Genomics, Society and Policy, 2 (3): 1-15.
42. BIS (ca. 2009) ‘The pharmaceutical sector in the UK’, Dept of Business, Innovation and Skills handout.
43. Blair, A. ‘Our Nation’s Future’, speech delivered at the Royal Society in Oxford, 3 November 2006.
44. Blair, A. (2007) ‘Speech at Blenheim Palace’, delivered 1 October 2007.
45. Blaxter, M. (2004) Health and Lifestyles, London: Routledge.
46. Bloomberg(2008) ‘Supergene labs design microbes to change sun to fuel, eat waste’, Bloomberg 9 January 2008.
47. BMJ (2006) ‘International consumer group slates drug marketing practices’British Medical Journal, 333: 14.
48. BMJ (2007) ‘Should genetic information be disclosed to insurers?’BMJ334: 1196-7.
49. Boddington, P. and Clarke, A. (2004) ‘It’s only teeth - limits to genetic testing? A response to Aldred, Crawford, Savarirayan, and Savulescu’, Clinical Genetics66: 562-4.
50. Boddington, P. and Gregory, M. (2008) ‘Communicating genetic information within the family:enriching the debate through the notion of integrity’Medicine, Health Care and Philosophy11 (4): 445-54.
51. Boddington, P. and Hogben, S. (2006a) ‘Working up policy: the use of specific disease exemplars in formulating general principles governing childhood genetic testing’, Health Care Analysis14 (1): 1-13.
52. Boddington, P. and Hogben, S. (2006b) ‘The rhetorical construction of ethical positions:policy recommendations for non-therapeutic genetic testing in childhood’, Communication and Medicine3 (2): 135-46.
53. Borry, P., Stultiens, L., Nys, H. et al. (2006) ‘Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers’, Clinical Genetics70 (5): 374-81.
54. Borry, P., Goffin, T., Nys, H. et al. (2008) ‘Predictive genetic testing in minors for adult-onset genetic diseases’, Mount Sinai Journal of Medicine75 (3): 287-96.
55. Bowring, F. (2003)Science, Seeds and Cyborgs: Biotechnology and the Appropriation of Life, London: Verso.
56. Bristol (2008) ‘Adult stem cell breakthrough’, University of Bristol press release 19 November 2008.
57. Brown, N. and Michael, M. (2003) ‘A sociology of expectations: retrospecting prospects and prospecting retro-spects’, Technology Analysis and Strategic Development15 (1): 3-18.
58. Brown, P. and Zavestoski, S. (2004) ‘Social movements in health: an introduction’, Sociology of Health and Illness26 (6): 679-94.
59. Bryan, E. (2007)Singing the life; the story of a family in the shadows of cancer, London: Vermilion.
60. Bucchi, M. (2004) ‘Can genetics help us rethink communication? Public communication of Science as a “double helix”’New Genetics and Society23: 3.
61. Buckley, F. and Buckley, S.J. (2008) ‘Wrongful deaths and rightful lives - screening for Down syndrome’, Down Syndrome Research and Practice12 (2): 79-86.
62. Burnham (2009) ‘The Research of Professor Evan Snyder into Cystic Fibrosis’, (Advisory), La Jolla: Burnham Institute for Medical Research.
63. Consumers Association (2008) ‘Which? warns consumers against costly genetic tests’, Consumers’ Association press release, 7 July 2009.
64. Cabinet Office (2007)Effective Consultation, London: Cabinet Office.
65. Cabinet Office (2008)Code of Practice on Consultation, London: Cabinet Office.
66. Cardiff (2006) ‘BBC Documentary explores University Research’, Cardiff University press release 21 September 2006.
67. Carroll, W. and Ratner, R. (1996) ‘Master framing and cross-movement metworking in contemporary social movements’, Sociological Quarterly37 (4): 601-25.
68. CEC (2001) ‘Proposal for a decision of the European Parliament and the Council concerning the multiannual framework programme 2002-6 of the European Community for Research, Technological Development and Demonstration’, OJ 21 February 2001 COM (2001) 94.
69. CEC (2002)Life Sciences and biotechnology: A strategy for Europe, Brussels: European Commission.
70. CEC (2004) ‘Directive 2004/23/EC on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells’, OJ 7 April 2004.
71. CEC (2007a) Budget breakdown of the Seventh Framework Programme of the European Community [Leaflet] Brussels: European Commission
72. CEC (2007b)FP7 in Brief (Leaflet) Luxembourg: European Commission.
73. Celera (2008)Celera Corporation Annual Report, Alameda, CA: Celera Corporation.
74. Chadwick, R. (2005) ‘HUGO Ethics Committee: ten years on’, SCRIPTed2 (2): 134-5.
75. Chadwick, R., Have, H., Husted, J. et al. (1998) ‘Genetic screening and ethics: European perspectives’, Journal of Medicine and Philosophy23 (3): 255-73.
76. Chan, C.K. and de Wildt, G. (2007)Developing Countries, Donor Leverage, and Access to Bird Flu Vaccines, New York: United Nations (DESA).
77. Chesters, G. and Welsh, I. (2006)Complexity and Social Movements: Protest at the Edge of Chaos, London: Routledge.
78. Christiani, D., Ashfari, C., Balbus, J. et al. (2007)Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment, Washington. DC: National Academies Presshttp://books.nap.edu/catalog.php?record_id=12037
79. Clarke, A. (ed.) (1998)The Genetic Testing of Children, Oxford: Bios Scientific Publishers.
80. Clinton and Blair (2000) ‘Joint Statement - President Clinton and Prime Minister Blair’, White House press release 14 March.
81. Collins, H.M. and Evans, R. (2002) ‘The third wave of science studies’, Social Studies of Science32 (2): 235-96.
82. Computer Weekly(2008) ‘Police to be allowed searches of national database of NHS patient records’, 28 February 2008.
83. Consumers International (2006)Branding the Cure, London: Consumers International.
84. CORE (ca. 2005) ‘About CORE’ http://www.corethics.org/index.php?c=a (accessed 26 May 2009).
85. Corporate Watch (2005a) ‘Nanotechnology: What it is and how corporations are using it’Corporate Technologies1.
86. Corporate Watch (2005b) ‘How many anti-nano Angels can dance on the head of a pin?’Corporate Watch Newsletter22: 8.
87. Corporate Watch (2007)Nanomaterials: Undersized, Unregulated and Already Here, London: Corporate Watch.
88. Corporate Watch (2009) Nestlé SA http://www.corporatewatch.org.uk/?lid=240
89. Corrigan, O. (2003) ‘Empty Ethics: The problem with informed consent’, Sociology of Health and Illness25 (3): 768-92.
90. Coviello, D.A., Brambati, B., Tului, L. et al. (2004) ‘Pre First-trimester prenatal screening for the common 35delG GJB2 mutation causing prelingual deafness’, Prenatal Diagnosis24 (8): 631-4.
91. Cummins, J. (ca. 2008) ‘Cauliflower mosaic virus recombination, when and where?’ Third World Network http://www.twnside.org.sg/title/mosaic-cn.htm (accessed 15 February 2009).
92. Custer, N.V. (2004) Protein Synthesis http://www.contexo.info/DNA_Basics/Protein_synthesis.htm (accessed 8 June 2009).
93. Cutter, A.M. (ed.) (2006) ‘Special Issue - Genomics and Criminal Justice’, Genomics, Society and Policy, 2 (1).
94. DAA (2000) ‘Opinion: the disabling story of gene therapy’, Disability Tribune, February. http://web.archive.org/web/20060518175427/www.daa.org.uk7etribune%5ce 2000 02htm
95. Daar, A.S. and Khitamy, A. (2001) ‘Islamic bioethics’, Canadian Medical Association Journal, 9 January, 164 (1).
96. Daily Mail(2009) ‘My Breasts Could Kill Me’, Daily Mail 6 July 2009.
97. Dawkins, R. (1976)The Selfish Gene, Oxford: Oxford University Press.
98. Davey Smith, G. and Ebrahim, S. (2005) ‘What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? British Medical Journal 330, 7 May, 1076-9.
99. Davey-Smith, G., Ebrahim, S., Lewis, S. et al. (2005) ‘Genetic epidemiology and public health: hope, hype, and future prospects’, The Lancet, 366 (9495): 1484-98.
100. DCA (1998)Data Protection Act, London: Dept for Constitutional Affairs.
101. deCODE (2007) deCODE genetics, Inc Annual Report, Reykjavik: decode.
102. Defra (2002)Defra's Horizon Scanning Strategy for Science, London: Defra.
103. Deleuze, G. and Guattari, F. (1987)A thousand plateaus: Capitalism and schizophrenia, Minneapolis: University of Minnesota Press.
104. Dept for Work and Pensions (2009)Households Below Average Income, London: The Stationery Office.
105. Dept of Health (2003)Our inheritance, our future: realising the potential of genetics in the NHS, London: The Stationery Office.
106. Dept of Health (2004a)The Medicines for Human Use (Clinical Trials) Regulations 2004, Statutory Instrument 2004/1031.
107. Dept of Health (2004b)Human Tissue Act 2004, London: The Stationery Office.
108. Dept of Health (2008a)End of Life Care Strategy, London: The Stationery Office.
109. Dept of Health (2008b)The potential impact of an opt out system for organ donation in the UK: an independent report from the Organ Donation Taskforce, London: The Stationery Office.
110. Dept of Health (2008c)Human Fertilisation and Embryology Act 2008, London: The Stationery Office.
111. Dept of Health and ABI (2005)Concordat and moratorium on genetics and insurance. London: Dept of Health.
112. Di Chiro, G. (2004a) ‘Local actions, global visions: remaking environmental expertise’, in Eglash, R., Croissant, J., Di Chiro, G., et al. (eds) Appropriating Technology: Vernacular Science and Social Power, Minneapolis: University of Minnesota Press.
113. Di Chiro, G. (2004b) ‘Producing “roundup ready(r)” communities? Human genome research and environmental justice policy’, in Stein, R. (ed.)New Perspectives on Environmental Justice: Gender, Sexuality, and Activism, New Brunswick: Rutgers University Press.
114. Di Chiro, G. (2007) ‘Indigenous peoples and biocolonialism: Defining the “science of environmental justice” in the century of the gene’, in Sandler, R. and Pezzullo, P. (eds) Environmental Justice and environmentalism: the social justice challenge to the environmental movement, Cambridge, MA: MIT Press.
115. Di Chiro, G. (2008) ‘Seeking the new biological fix? Public health genetics and environmental justice policy’, in Molfino, F. and Zucco, F. (eds) Women in Biotechnology: Creating Interfaces, New York: Springer.
116. Diani, M. (1992) ‘Analysing Social Movement Networks’, in Diani, M. and Eyerman, R. (eds) Studying Collective Action, London: Sage.
117. Dickenson, D. (2002) ‘Commodification of human tissue: implications for feminist and development ethics’, Developing World Bioethics, 2 (1): 62.
118. Dickenson, D. (2007)Property in the body: feminist perspectives, Cambridge: Cambridge University Press.
119. Dobson, A. (2003)Citizenship and the Environment, Oxford: Oxford University Press.
120. Dobson, A. (2006) ‘Ecological citizenship: a defence’, Environmental Politics15 (3): 447-51.
121. Doherty, B., Plows, A. and Wall, D. (2003) ‘The preferred way of doing things: The British direct action novement’, Parliamentary Affairs56: 669-86.
122. Doherty, B., Plows, A. and Wall, D. (2007) ‘Environmental direct action in Manchester, Oxford and North Wales: a protest event analysis’, Environmental Politics16 (5): 805-25.
123. Dryzek, J. S. (2000)Deliberative Democracy and Beyond: Liberals, Critics, Contestations, Oxford: Oxford University Press.
124. DTI (2002)New Dimensions for Manufacturing: A UK Strategy for Nanotechnology, London: DTI.
125. ECHR (2008) ‘Grand Chamber Judgement S. and Marper v. The United Kingdom’, ECHR press release 4 December 2008.
126. EGE (2000)Ethical aspects of human stem cell research and use, Brussels: European Commission.
127. EGE (2005)General Report on the Activities of the European Group on Ethics in Science and New Technologies to the European Commission 2000-2005, Luxembourg: European Communities.
128. EGP (1997)Environmental Genome Project, Research Triangle Park: NIEHS.
129. Einsiedel, E., Allum, N., Bauer, M. et al. (2003) ‘Brave new sheep - the clone named Dolly’, in Bauer, M. and Gaskell, G. (eds) Biotechnology: The Makings of a Global Controversy, Cambridge: Cambridge University Press.
130. E-Petition (2007) ‘Stop DNA by Stealth’, (Petition) http://petitions.pm.gov.uk/StopDNAbystealth/ (accessed 16 May 2007).
131. Epstein, S. (2004) ‘Bodily differences and collective identities: the politics of gender and race in biomedical research in the United States’, Body & Society10 (2-3): 183-203.
132. Epstein, S. (2007)Inclusion. The Politics of Difference in Medical Research, Chicago: University of Chicago Press.
133. Eriksson, L. (2004) ‘When Scientists Fight’, Science & Public Affairs, June, 25.
134. Eschle, C. (2001) ‘Globalizing civil society? Social movements and the challenge of global politics from below’, in Hamel, P., Lustiger-Thaler, H., Pieterse, J. et al. (eds) Globalization and Social Movements, Basingstoke: Palgrave Macmillan.
135. Eschle, C. and Stammers, N. (2005) ‘Social movements and global activism’, in De Yong, W, Shaw, M. and Stammers, N. (eds) Global Activism, Global Media, London: Pluto Press, pp. 50-67.
136. ESSFN (2005) Framework Programme 7: Towards a real partnership with society, European Science Social Forum Network http://www.scienceforthepeople.com/index.php?name=News&file=article& sid=59
137. ETC Group (2003)The Big Down: Atomtech - Technologies Converging at the Nanoscale, Ottawa: ETC Group.
138. ETC Group (2004) ‘White papers, red flags, green goo, grey goo (and red herrings)’, ETC Group Communiqué Issue 85.
139. ETC Group (2008a)Direct-to-Consumer DNA Testing and the Myth of Personalized Medicine: Spit Kits, SNP Chips and Human Genomics, Ottawa: ETC Group.
140. ETC Group (2008b) ‘Who owns nature? Corporate power and the final frontier in the commodification of life’, ETC Group Communiqué Issue 100.
141. ETC Group (2009) The Issues http://www.etcgroup.org/en/issues/ (accessed 29 May 2009).
142. Ethox (2005) ‘Governing genetic databases’ (Mission statement).
143. Eurobarometer (2009)European cross-national, longitudinal survey, Brussels: CEC.
144. Evans, R and Plows, A. (2007) ‘Listening without prejudice? Re-discovering the value of the disinterested citizen’, Social Studies of Science 37 (6): 827-53.
145. Evans, R., Welsh, I. and Plows, A. (2006) ‘Towards an anatomy of public engagement with medical genetics: strange bedfellows and usual suspects’, in Atkinson, P., Glasner, P. and Greenslade, H.(eds) New Genetics, New Identities, London: Routledge.
146. Evans, R., Welsh, I. and Plows, A. (2008) ‘Just around the corner: rhetorics of progress and promise in genetic research’, Public Understanding of Science18 (1): 43-59.
147. Evans, W.E. and Relling, M. (1999) ‘Pharmacogenomics: translating functional genomics into rational therapeutics’, Science286: 487-91.
148. Featherstone, K., Atkinson, P., Bharadwaj, A. et al. (2006)Risky relations: family, kinship and the new genetics, Oxford: Berg.
149. Financial Times(2009) ‘Are medical surveys good for our health?’ 7 February.
150. Fischer, F. (2000)Citizens, Experts, and the Environment: The Politics of Local Knowledge, Durham, NC: Duke University Press.
151. Fitzpatrick, M. (2001)The Tyranny of Health: Doctors and the Regulation of Lifestyle, London: Routledge.
152. Ford, L.H. (2003) ‘Challenging global environmental governance: social movement agency and global civil society’, Global Environmental Politics, 3 (2): 120-34.
153. Foucault, M. (2003) ‘The birth of biopolitics’, in Rabinow, P. and Rose, N. (eds) The Essential Foucault: Selections From the Essential Works of Foucault 1954-1984, New York: New Press.
154. Franklin, S. (2007)Dolly Mixtures: the remaking of genealogy, Durham, NC: Duke University Press.
155. Franklin, S. (2008) ‘Embryo transfer: a view from the United Kingdom’, in Molfino, F. and Zucco, F. (eds) Women in Biotechnology: Creating Interfaces, New York: Springer.
156. Franklin, S. and Roberts, C. (2006)Born and Made: An Ethnography of Preimplantation Genetic Diagnosis, Princeton, NJ: Princeton University Press.
157. Fukuyama, F. (2002)Our Posthuman Future: Consequences of the Biotechnology Revolution, New York: Farrar, Straus, and Giroux.
158. Furedi, Frank (2002)Culture of fear: risk-taking and the morality of low expectation, London: Continuum.
159. Gardner, P. (2003) ‘Distorted packaging: marketing depression as illness, drugs as cure’, Journal of Medical Humanities24: 105-30.
160. Gelsinger, P. (2008) ‘A comment from Paul Gelsinger on gene therapy and informed consent’, American Journal of Bioethics blog.bioethics.net http://blog.bioethics.net/2008/01/a-comment-from-paul-gelsinger-on-gene-therapy-and/ accessed 15 February 2009.
161. GeneWatch (2000)Privatising Knowledge, Patenting Genes: The Race to Control Genetic Information #Briefing 11, Buxton: GeneWatch.
162. GeneWatch (2002a)Human Genetics and Health, Buxton: GeneWatch.
163. GeneWatch (2002b)Genetically Modified and Cloned Animals. All in a Good Cause? Buxton: GeneWatch.
164. GeneWatch (2004) ‘Bar-Coding Babies: Good for Health?’ GeneWatch #Briefing 27, 1 August 2004, Buxton: GeneWatch.
165. GeneWatch (2004)Genetic Tests and Health; the Case for Regulation #Briefing 28, Buxton: GeneWatch.
166. GeneWatch (2005)The Police National DNA Database: Human Rights and Privacy, Buxton: GeneWatch.
167. GeneWatch (2006a) ‘NDNAD facts and figures’ http://www.genewatch.org/sub.shtml?als[cid]=539481 (accessed 16 May 2007).
168. GeneWatch (2006b)Using the police National DNA Database - under adequate control? Buxton: GeneWatch.
169. GeneWatch (2007) ‘Regulation needed to prevent human genome from becoming massive marketing scam’, GeneWatch press release 29 October 2007.
170. GeneWatch (2008) Modernising police powers http://www.genewatch.org/sub/shtml?als[cid]=551990 (accessed 16 May 2007).
171. GeneWatch (2009a) GeneWatch UK believes that genetic horoscopes are a dangerous myth’ http://www.genewatch.org/sub.shtml?als%5Bcid%5D=532295 (accessed 10 February 2009).
172. GeneWatch (2009b)Is ‘early health' good health? The implications of genomic data-mining in the NHS, Buxton: GeneWatch.
173. GeneWatch (2009c)Examples of genes and common diseases, Buxton: GeneWatch.
174. GeneWatch (2009d) ‘A brief legal history of the NDNAD’ http://www.genewatch.org/sub.shtml?als[cid]=537968 (accessed 16 May 2007).
175. GeneWatch, ARCH, Liberty (2007) NDNAD: proposed expansions of powers, Buxton: GeneWatch.
176. Genographic Project (2008) ‘Your genetic journey’ (Brochure).
177. GHR (2008) ‘What are the CYP genes?’Genetics Home Reference, Bethesda: U.S. National Library of Medicine.
178. Gibbons, S.M.C., Kaye, J., Smart, A. et al. (2007) ‘Governing genetic databases: challenges facing research regulation and practice’. Journal of Law and Society34 (2): 163-89.
179. Gibson, A.G. (1933)The Physician 's Art, Oxford: The Clarendon Press.
180. Glasner, P. and Rothman, H. (2004)Splicing Life? The New Genetics and society, Aldershot: Ashgate.
181. Goffman, E. (1974)Frame analysis: An essay on the organization of experience, New York: Harper & Row.
182. Goodman, E. and Adler, N. (2007) ‘The biology of social justice: linking social inequalities and health in adolescence’, in Wainryb, C., Smetana, J. and Elliot Turiel, T.(eds) Social Development, Social Inequalities, and Social Justice, London: Psychology Press.
183. Granovetter, M.S. (1973) ‘The strength of weak ties’, American Journal of Sociology78 (6): 1360-80.
184. Green Action (2004)Technology, Politics, and Democracy, Belfast: Green Action.
185. Greenpeace (2005) ‘Nano jury “verdict” calls for more public say and clarity on nanotechnology’, Greenpeace press release 21 September 2005.
186. Grove-White, R., Macnaghten, P. and Wynne, B. (2000), Wising Up: The public and new technologies, Lancaster: IEPPP.
187. Guardian (2000) ‘DNA sequences (partial and complete gene sequences) which have been recorded in patents from 40 patent authorities worldwide’, 8 March 2000.
188. Guardian (2002) ‘One man and his worm’, 9 October 2002.
189. Guardian (2006) ‘Controversial conceptions’, 9 May 2006.
190. Guardian (2008a) ‘Early humans helped to develop with “junk” DNA’, 5 September 2008.
191. Guardian (2008b) ‘Hannah’s Choice’, 12 November 2008.
192. Guardian (2008c) ‘Father tells inquest of son’s dying moments’, 11 December 2008.
193. Guardian (2009a) ‘She may never get breast cancer - but girl’s birth raises new doubts over designer babies’, 10 January 2009.
194. Guardian (2009b) ‘“Neanderthals” genetic code reconstructed by researchers’. 13 February 2009.
195. Habermas, J. (1981)The theory of communicative action, Boston: Beacon Press.
196. Habermas, J. (1987)The theory of communicative action: A critique off unctionalist reason, vol. 2, Lifeworld and System, London: Polity Press.
197. Habermas, J. (2003)The Future of Human Nature, Oxford: Polity Press.
198. Hamilton, W.D. (1964). ‘The genetical evolution of social behavior’, Journal of Theoretical Biology 7 (1): 1 -52.
199. Hammersley, M. (ed.) (1993)Social Research: Philosophy, Politics and Practice, London: Sage.
200. Hansard (2002)HL debate Stem Cell Research, Hansard 5 December 2002: col. 1311.
201. Hansard (2004) ‘Human fertilisation and embryology act donor identity’, Hansard 21 January 2004: col. 60WS.
202. Hansard (2006a) ‘DNA database volunteers’, Hansard 16 January 2006: col. 1094W.
203. Hansard (2006b) ‘DNA database under 18’, Hansard 2 May 2006: col. 1409W
204. Hansard (2007a) ‘HL debate stem cell research’, Hansard 3 May 2007: col. 1163.
205. Hansard (2007b) ‘Genetics: databases’, Hansard 10 May 2007: col. 427W.
206. Hansard (2008) ‘Human fertilisation and embryology bill debate’, Hansard 12 May 2008: col. 1063.
207. Haran, J. and O’Riordan, K. (2006) ‘Women, feminism and human cloning: recirculating concerns and critiques’, Feminist Media Studies6(2): 217-22.
208. Haran, J., Kitzinger, J., McNeil, M. and O’Riordan, K. (2007)Human Cloning in the Media: From Science Fiction to Science Practice, London: Routledge.
209. Haraway, D. (1991) ‘A cyborg nanifesto: science, technology, and socialist-feminism in the late twentieth century’, in Simians, Cyborgs and Women: The Reinvention of Nature, New York, London: Routledge.
210. Harcourt, W. (2008) ‘Heading blithely down the garden path? Some entry points into current debates on women and biotechnologies’, in Molfino, F. and Zucco, F. (eds) Women in Biotechnology: Creating Interfaces, New York: Springer.
211. Harris, J. (2005) ‘Scientific research is a moral duty’, Journal of Medical Ethics31: 242-8.
212. Harry, D., Howard, S. and Shelton, B.(2000)Indigenous Peoples, Genes and Genetics. What Indigenous People Should Know About Biocolonialism, Nixon, NV: Indigenous Peoples Council on Biocolonialism.
213. Hayward, T. (2005)Constitutional Environmental Rights, Oxford: Oxford University Press.
214. Hayward, T. (2006) ‘Ecological citizenship: justice, rights and the virtue of resourcefulness’, Environmental Politics15(3): 435-46.
215. HC 2005House of Commons Science and Technology Committee: Forensic Science on Trial, London: The Stationery Office.
216. HC (2007)House of Commons Science and Technology Committee: Fifth Report, London: The Stationery Office.
217. HoC Library (2009)Retention of fingerprint and DNA data, London: HoC Library.
218. HealthDataRights (2009) ‘Thought-leaders unite to release declaration of health data rights’, Health Data Rights press release 22 June 2009.
219. Herring, J. (2006)Medical Law and Ethics, Oxford: Oxford University Press.
220. HFEA (2001) ‘HFEA to allow tissue typing in conjunction with preimplantation genetic diagnosis’ HFEA Press Release 13 Dec 2001.
221. HFEA (2003) ‘Court of Appeal allows tissue typing for human embryos under strict conditions’, HFEA press release 12 March 2009.
222. HFEA (2006)Donating eggs for research: safeguarding donors, London: HFEA.
223. HFEA (2007) ‘Statement on donating eggs for research’, HFEA press release 21 February 2007.
224. HGA (2000)The regulation of pre-implantation genetic diagnosis, London: HGA.
225. HGA (2003) ‘Why it is wrong to select embryos to be tissue donors’ (Commentary) press release 20 June.
226. HGC and NSC (2005)Profiling the Newborn, London: Human Genetics Commission.
227. HGC (2002)Inside Information: Balancing Interests in the Use of Genetic Data, London: Human Genetics Commission.
228. HGC (2003)Direct Genetic Testing, London: Human Genetics Commission.
229. HGC (2004)Choosing the future:genetics and reproductive decision making, London: Human Genetics Commission.
230. HGC (2007)Joint committee on the Human Tissue and Embryos (Draft) Bill – First Report, HC 630-I, HL Paper 169-I 1 August 2007, London: The Stationery Office.
231. HGC (2009)Genomic Medicine Inquiry, London: The Stationery Office.
232. Ho, M-W. (2003)Living With the Fluid Genome, London: Institute of Science and Society.
233. Hogben, S. and Boddington, P. (2005) ‘Policy recommendations for carrier testing and predictive testing in childhood: a distinction that makes a real difference’, Journal of Genetic Counselling14 (4): 271-82.
234. Home Office (2006)DNA Expansion Programme 2000-2005: Reporting achievement, London: Home Office.
235. Home Office (2007a)Modernising Police Powers: Review of the Police and Criminal Evidence Act (PACE) 1984, (March 2000) London: Home Office.
236. Home Office (2007b) ‘Thousands of “cold cases” to be reviewed’, Home Office press release 11 September 2007.
237. Home Office (2009)Research and testing using animals, Home Office handout.
238. HOOO (2006) ‘Korea Herald: Seoul tightens egg/sperm donation rules’, Hands off our ovaries Newsletter, 20 November 2006.
239. Hope (2004)Medical Ethics: a Very Short Introduction, Oxford: Oxford University Press.
240. Hopkins, M.M., Martin, P., Nightingale, P. et al. (2007) ‘The myth of the biotech revolution: An assessment of technological, clinical and organisational change’, Research Policy36 (4): 566-89.
241. Horlick-Jones, T., Walls, J., Rowe, G. et al. (2007)The GM Debate: Risk, Politics and Public Engagement, London: Routledge.
242. Horlick-Jones, T., Walls, J. and Kitzinger, J. (2007) ‘Bricolage in action: learning about, making sense of, and discussing, issues about genetically modified crops and food’, Health, Risk & Society9 (1): 83-103.
243. Howard, S. (2001)Life, Lineage and Sustenance: Indigenous Peoples and Genetic Engineering, Threats to Food, Agriculture and the Environment, Nixon, NV: Indigenous Peoples Council on Biocolonialism.
244. HUGO (2000)Statement on Benefit-Sharing, Vancouver: HUGO.
245. Hütter, G., Nowak, D., Mossner, M. et al. (2009) ‘Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation’, New England Journal of Medicine360 (7): 692-8.
246. Illich, I. (1975)Limits to Medicine: Medical Nemesis The Appropriation of Health, London: Marian Boyers.
247. Independent(1997) ‘After Dolly comes Polly, the sheep with human genes’, 25 July 1997.
248. Independent (2008) ‘Brown wins 42-day detention vote by a whisker’, 11 June 2008.
249. Independent (2009) ‘Gene therapy offers hope of cure for HIV’, 12 February 2009.
250. IPO (2009)IPO Examination Guidelines for Patent Applications relating to Biotechnological Inventions in the Intellectual Property Office, Newport, Gwent: IPO.
251. Irwin, A. (1995)Citizen Science; A Study of People, Expertise and Sustainable Development, London: Routledge.
252. Irwin, A. and Michael, M. (2003)Science, Theory and Public Knowledge, Maidenhead: Open University Press.
253. Irwin, A. and Wynne, B. (eds) (1996)Misunderstanding Science? The Public Reconstruction of Science and Technology, Cambridge: Cambridge University Press.
254. ISB (2008)Institute for Systems Biology Annual Report 2007Seattle: ISB.
255. ISESCO (2005) ‘Human Genetic and Reproductive Technologies: Comparing Religious and Secular Perspectives’ Seminar in 2005 Organised by The Islamic Educational Scientific & Cultural Organisation (ISESCO) and Human Genetics Alert (HGA), London.
256. Ishiguro, K. (2005)Never Let Me Go, London: Faber and Faber.
257. Jasanoff, S. (1990)The fifth branch. Science advisers as policymakers, Cambridge, MA: Harvard University Press.
258. Jasanoff, S. (1995) ‘Product, process, or programme: three cultures and the regulation of biotechnology’, in Bauer, M. (ed.) Resistance to New Technology, Cambridge: Cambridge University Press.
259. Jasanoff, S. (2005a)Designs on Nature: Science and Democracy in Europe and the United States, Princeton, NJ: Princeton University Press.
260. Jasanoff, S. (2005b) ‘Science and environmental citizenship’, in Dauvergne, P. (ed.)Handbook of Global Environmental Politics, Cheltenham: Edward Elgar.
261. JINBO (2003) Struggle for Access to Glivec in South Korea http://glivec.jinbo.net/what_en.html (accessed 29 May 2009).
262. KCL (2004) ‘Stem cell hope for degenerative disorders’. King’s College London press release 8 September 2004.
263. Keller, E.F. (2000)The Century of the Gene, Harvard: Harvard University Press.
264. Kerr, A. and Shakespeare, T. (2002)Genetic Politics - From Eugenics to Genome, Gloucester: New Clarion Press.
265. Kerr, A., Cunningham-Burley, S. and Amos, A. (1998a) ‘The new genetics and health: mobilizing lay expertise’, A Public Understanding of Science 7: 41-60.
266. Kerr, A., Cunningham-Burley, S. and Amos, A. (1998b). ‘Drawing the line: an analysis of lay people’s discussion about the new genetics’, A Public Understanding of Science7: 113-33.
267. King’s Fund (2008)NHS spending: Local variations in priorities: an update, London: King’s Fund.
268. Knorr-Cetina, K. (1999)Epistemic Cultures: How the Sciences Make Knowledge, Cambridge, MA: Harvard University Press.
269. Lackner, K.J. (2002) ‘From pharmacogenetics to pharmacogenomics’, Trends in Pharmacological Sciences23(1): 46.
270. Latour, B. (1993)We Have Never Been Modern, Cambridge, MA: Harvard University Press.
271. Latour, B. and Woolgar, S. (1979)Laboratory Life: The Social Construction of Scientific Facts, London: Sage.
272. Law, J. (2006)After Method: Mess in Social Science Research, London: Routledge.
273. Leehey, M., Munhoz, R., Lang, A. et al. (2003) ‘The fragile X premutation presenting as essential tremor’Archives of Neurology60: 117-21.
274. Levitt, M. and Tomasini, F. (2006) ‘Bar-coded children: an exploration of issues around the inclusion of children on the England and Wales National DNA database’, Genomics, Society and Policy2 (1): 41-56.
275. Liberty (2008) ‘Shadow Home Secretary resigns over extending pre-charge detention for terror suspects to 42 days’ Liberty press release 12 June.
276. Lichtenstein, P., Holm, N., Verkasalo, P. et al(2000) ‘Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland’, New England Journal Medicine July, 343 (2): 78-85.
277. Lippman, A. (1991) ‘Prenatal genetic testing and screening: constructing needs and reinforcing inequities’, American Journal of Law and Medicine17 (1-2): 15-50.
278. Lunshof, J., Chadwick, R., Vorhaus, D. et al. (2008) ‘From genetic privacy to open consent’, Nature Reviews Genetics May, 9: 406-11.
279. McAdam, D. (1986) ‘Recruitment to high-risk activism: the case of Freedom Summer’, American Journal of Sociology92 (1): 64-90.
280. McConkie-Rosell, A. and DeVellis, B.M. (2000) ‘Threat to parental role: a possible mechanism of altered self-concept related to carrier knowledge’, Journal of Genetic Counseling9 (4): 285-302.
281. McKibben, B. (2003)Enough: Staying Human in an Engineered Age, New York: Henry Holt.
282. Macmillan Cancer Support (2009) ‘A breast cancer break through’, 11 January 2009 http://www.whatnow.org.uk/blog/jan2/breast-cancer-break-through (accessed 18 June) 2009.
283. McMurtry, J. (1999)The Cancer Stage of Capitalism, London: Pluto Press.
284. McNally, R. and Glasner, P. (2007)Survival of the gene? Twenty first century visions from genomics, proteomics and the new biology, London: Routledge.
285. Magnus, D. and Cho, M.K. (2006) ‘Issues in oocyte donation for stem cell research’, Science 19 May 2005.
286. Marks, J. (2007)‘How does genomics change our understanding of society?’ Keynote speech at the Economic and Social Research Council’s Genomics Network conference ‘Today Answers, Tomorrow Questions’, London, 25 October 2007 available as an MP3 audio file at http://www.genomicsnetwork.ac.uk/media/marksnoq&a2.mp3 (accessed 16 June 2009).
287. Marmot, M.G and Shipley, M.J (1996) ‘Do socioeconomic differences in mortality persist after retirement? 25 Year follow up of civil servants from the first Whitehall study’, BMJ313: 1177-80.
288. Mayer, S. (2002). ‘From genetic modification to nanotechnology: the dangers of “sound science”’, in Gilland, T. (ed.) Science: can we trust the experts? London: Hodder & Stoughton.
289. Mayrhofer, M. and Prainsack, B. (2009), ‘Being a member of the club: the transnational (self-)governance of networks of biobanks’, International Journal of Risk Assessment and Management12 (1): 64-81.
290. Melucci, A. (1996)Challenging Codes: Collective Action in the Information Age, Cambridge: Cambridge University Press.
291. MHRA (2008)Who makes the decisions? (Leaflet), February.
292. Midden, C., Boy, D., Einsiedel, E. et al. (2002) ‘The structure of public perceptions’, in Bauer, M. and Gaskell, G. (eds) Biotechnology: The Makings of a Global Controversy, Cambridge: Cambridge University Press.
293. Mies, M. and Shiva, V. (1993)Ecofeminism, London: Zed Books.
294. Miller, P. and Wilsdon, J. (eds) (2006)Better Humans? The politics of human enhancement and life extension, London: Demos.
295. Mitchell, D. (2004)Cloud Atlas, London: Sceptre.
296. Mohrenweiser, H., Wilson, D. and Jones, I. (2003) ‘Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes’, Mutation Research/ Fundamental and Molecular Mechanisms of Mutagenesis526 (1): 93-125.
297. MRC (2005)Research regulation and ethics, London: MRC.
298. Mulkay, M. (1993) ‘Rhetorics of hope and fear in the great embryo debate’, Social Studies of Science23 (4): 721-42.
299. Nahman, M. (2006) ‘Materializing Israeliness: difference and mixture in transnational ova donation’, Science as Culture15 (3): 199-213.
300. Nature (2006a) ‘Rise and fall’, Nature 11 January 2006.
301. Nature (2006b) ‘Health effects of egg donation may take decades to emerge’, Nature 9 August 2006.
302. NBPA (2006) ‘DNA breakthrough’, National Black Police Association press release 16 October 2006.
303. NCoB (2002)Genetics and Human Behaviour: the Ethical Context, London: Nuffield Council on Bioethics.
304. NCoB (2003)Pharmacogenetics: Ethical Issues, London: Nuffield Council on Bioethics.
305. NCoB (2006) ‘Ethical questions over police use of DNA’, Nuffield CoB press release 1 November 2006.
306. NCoB (2007) ‘DNA of innocent people should not be kept by police’, Nuffield CoB press release 18 September 2007.
307. NDNAD Ethics Group (2008)1st Annual Report by the National DNA Database Ethics Group, London: NPIA.
308. Nelkin, D. (1995) ‘Forms of intrusion: comparing resistance to information technology and biotechnology in the USA’, in Bauer, M. (ed.)Resistance to new Technology: Nuclear Power, Information Technology and Biotechnology, Cambridge: Cambridge University Press.
309. NetDoctor (ca. 2008) Why is ADHD controversial? http://www.netdoctor.co.uk/adhd/whyisadhdcontroversial.htm (accessed 11 February 2009).
310. New Scientist(2002) ‘Genetic basis for lactose intolerance’, 14 January 2002.
311. New Scientist (2005a) ‘Stem cells turn into breast implants’, 18 February 2005.
312. New Scientist (2005b) ‘Will DNA profiling fuel prejudice?’ 8 April 2005.
313. New Scientist (2006a) ‘Interview: Tony Blair on science’, 4 November 2006.
314. New Scientist (2006b) ‘Catastrophic immune response may have caused drug trial horror’, 17 March 2006.
315. New Scientist (2008) ‘Junk DNA may have handed us a gripping future’, 4 September 2009.
316. New Scientist (2008) ‘Thousands volunteer to expose DNA secrets to the world’, 21 October 2008.
317. New York Times(2009) ‘A Genetics Company Fails, Its Research too Complex’ (Nicholas Wade), 17 November.
318. Ngwena, C. and Chadwick, R. (1993) ‘Genetic diagnostic information and the duty of confidentiality: ethics and law’, Medical law international1 (1): 73-95.
319. NHS (2007) ‘I want to try for a baby. Should I seek genetic counselling? NHS leaflet.
320. NHS (2009) ‘Gene “switches off cancer”’,’NHS News, 2 February 2009.
321. CSP (2004) ‘Cervical Screening Guide’, NHS leaflet.
322. NICE (2008) ‘Antenatal care: routine care for the healthy pregnant woman’, London: NICE.
323. Nightingale, P. and Martin, P. (2004) ‘The myth of the biotechnology revolution’, Trends in Biotechnology22 (11): 564-9.
324. NIH (1990) ‘Human Genome Project’, NIH press release.
325. NIH (2002a) ‘International consortium launches genetic variation mapping project: HapMap will help identify genetic contributions to common diseases’, NIH press release October 2002.
326. NIH (2002b) ‘The mouse genome and the measure of man’, NIH news advisory, December 2002.
327. NO2ID (2008) ‘Halt biometric bullying by roadside fingerprinting’, NO2ID press release 27 October 2008.
328. Nordmann, A. (2008) ‘No future for nanotechnology? Historical development vs global expansion’, in Jotterand, F. (ed.)Emerging Conceptual, Ethical and Policy Issues in Bionanotechnology, New York: Springer.
329. Norsigian, J. (2005) ‘Egg donation for IVF and stem cell research: time to weigh the risks to women’s health’, DifferenTakes 33, Spring.
330. NPIA (2007) Annual Report for the National DNA Database 2006 - 2007, London: National Policing Improvement Agency.
331. NSC (2005)Policy Review Process, London: National Screening Committee.
332. Observer (2006) ‘Police DNA database “is spiralling out of control”: Secret emails show private firms store genetic data from innocent victims’, 16 July 2006.
333. Observer (2008) ‘To save lives, we have to change attitudes to organ donation’, 16 November 2008.
334. Observer (2008) ‘Internet gene tests provoke alarm’, 3 February 2008.
335. OCA (2003) ‘Battle over cancer gene test U.S. company’s patenting claim called “abhorrent”’, Organic Consumers Association Newsletter, September 2003 http://www.purefood.org/Patent/010903_patent.cfm (accessed 8 March 2009).
336. OECD (2005) Organisation Chart, Paris: OECD.
337. OECD (2006)Creation and Governance of Human Genetic Research Databases, Paris: OECD.
338. OECD (2007a)Pharmacogenetics: Opportunities and Challenges for Health Systems, OECD handout.
339. OECD (2007b) ‘The impacts of pharacogenetics on health systems’, Health Update Newsletter2007 (3): 16.
340. OECD (2008)Guidelines for Human Biobanks and Genetic Research Databases, Paris: OECD.
341. OECD (2009a)Pharmacogenetics: Opportunities and Challenges for Health Systems, Paris: OECD.
342. OECD (2009b)The Bioeconomy to 2030: Designing a Policy Agenda, Paris: OECD.
343. O’Riordan, K. and Haran, J. (2009) ‘From reproduction to research: sourcing eggs, IVF and cloning in the UK’, Feminist Theory10 (2): 191-210.
344. PAE (2004) ‘Anti eugenics action’, People Against Eugenics press release 18 May 2003.
345. Parker, M. and Lucassen, A. (2003) ‘Concern for families and individuals in clinical genetics’, Journal of Medical Ethics29: 70-3.
346. Parry, S. (2006) ‘(Re)constructing embryos in stem cell research: Exploring the meaning of embryos for people involved in fertility treatments’, Social Science & Medicine62 (2006) 2349-59.
347. Pears, T. (2002)Wake up, London: Bloomsbury.
348. PET (2004) ‘HFEA to change its mind on “saviour siblings”?’ Progress Educational Trust press release.
349. PET (2005) ‘About BioNews’, BioNews http://www.bionews.org.uk/aboutbionews.lasso (accessed 2 September 2005).
350. PET (2007) FIND genetic databases used by the police help them solve http://www.progress.org.uk/Events/PastEventsDDNAC.html (accessed 16 May 2007).
351. PET (ca. 2008) About Progress Educational Trust http://www.progress.org.uk/About/Index.html (accessed 21 May 2009).
352. PHG (2006) ‘HFEA favours altruistic egg donation for cloning research’, Foundation for Genomics and Population Health press release 16 February 2006.
353. PHM (2009) Intellectual Property and Pharmaceuticals http://phmoz.org/wiki/index. php?title=Intellectual_Property_and_Pharmaceuticals (accessed 17 April 2009).
354. Pickering, S.J. and Braude, P. (2003) ‘Preimplantation genetic diagnosis as a novel source of embryos for stem cell research’, Reproductive biomedicine online (October) 7(3): 353-64 http://www.rbmonline.com/4DCGI/Article/2003/1074/RB1074.pdf (accessed 22 June 2009).
355. PICTF (2001)Pharmaceutical Industry Competitiveness Task Force: Final Report, London: The Stationery Office.
356. Plows, A. (2003) ‘Praxis and practice: the “what, how and why” of the UK environmental direct action (EDA) movement in the 1990s’, Ph.D. Bangor, University of Wales.
357. Plows, A. (2004) ‘Activist networks in the UK: mapping the build-up to the anti-globalization movement’, in Carter, J. and Morland, D. (eds) Anti-Capitalist Britain, Gloucester: New Clarion Press.
358. Plows, A. (2006) ‘PGD, PND and the challenge of “informed choice” for feminism’, PropEur newsletter2, p. 4.
359. Plows, A. (2007a) ‘You’ve been framed! Why publics mistrust the policy process’, Genomics Network newsletter6: 22-3.
360. Plows, A. (2007b) ‘Regulating egg donation for research: putting the cart before the horse?’Bionews 22 February 2007http://www.bionews.org.uk/commentary.lasso?storyid=3315
361. Plows, A. (2008a) ‘Social movements and ethnographic methodologies: an overview of key issues using case study examples’, Sociological Compass August 2008.
362. Plows, A. (2008b) ‘Egg donation in the UK: tracing emergent networks of feminist engagement in relation to HFEA policy shifts in 2006’, in Molfino, F. and Zucco, F. (eds) Women in Biotechnology: Creating Interfaces, New York: Springer.
363. Plows, A. (2008c) ‘Towards an analysis of the “success” of UK green protests’. British Politics (2008) 3: 92-109.
364. Plows, A. and Boddington, P. (2006) ‘Troubles with biocitizenship?’Genetics, Society and Policy2 (3): 115-35.
365. Plows, A. and Reinsborough, M. (2008) ‘Nanobiotechnology and ethics: converging civil society discourses’, in Jotterand, F. (ed.)Emerging Conceptual, Ethical and Policy Issues in Bionanotechnology, New York: Springer.
366. Plows, A., Wall, D. and Doherty, B. (2004) ‘Covert repertoires: ecotage in the UK’, Social Movement Studies 3 (2)199-219.
367. Plows, A., Haran, J. and O’Riordan, K. (2006)Should scientific researchers be allowed to ask women to provide their eggs for disease research?Cardiff: CESAGen.
368. Poore, C. (2007)Disability in Twentieth-Century German Culture, Ann Arbor: University of Michigan.
369. PR Watch (2003) ‘From patient activism to astroturf marketing’, PR Watch10 (1).
370. Prainsack, B., Reardon, J., Hindmarsh, R. et al. (2008) ‘Personal genomes: Misdirected precaution’, Nature456: 34-5.
371. Prime Minister’s Strategy Unit (2004)Personal Responsibility and Changing Behaviour: the state of knowledge and its implications for public policy, London: Cabinet Office.
372. Primrose, S.B. and Twyman, T.M. (2006)Principles of gene manipulation and genomics, Oxford: Blackwell.
373. PSP (2004)Public Attitudes to Stem Cell Research - establishing the UK stem cell bank, London: People Science and Policy.
374. Purdue, D. (2000)Anti-GentiX: The emergence of the Anti-GM movement, Aldershot: Avebury.
375. PXE (2004) ‘U.S. patent office issues first gene patent to patient advocacy group; co-inventors include non-scientist “Mom”’, PXE press release 24 August 2004.
376. Rabinow, P. (1996) ‘Artificially and enlightenment: from sociobiology to biosociality’, in Rabinow, P., Essays on the Anthropology of Reason, Princeton, NJ: Princeton University Press.
377. Rahman, Q. (2008) ‘Asbestos past experiences, nanoparticles future developments’, in Molfino, F. and Zucco, F. (eds) Women in Biotechnology: Creating Interfaces, New York: Springer.
378. Rajan, S.K. (2006)Biocapital: the constitution ofpostgenomic life, Durham, NC: Duke University Press.
379. Rapp, R. (1999)Testing Women, Testing the Fetus: The Social Impact of Amniocentesis in America, London: Routledge.
380. Rawlins, M.D. and Culyer, A.J. (2004) ‘National Institute for Clinical Excellence and its value judgments’, BMJ329 (7459): 224-7.
381. Register (2008) ‘How to delete your DNA profile’, The Register, 7 January 2008. http://www.theregister.co.uk/2008/01/07/delete_your_dna_profile/ (accessed 22 July 2009).
382. ReproKult (2005) Home Page http://www.reprokult.de/e_welcome.html (accessed 26 May 2005).
383. Richards, M. (2001) ‘How distinctive is genetic information?’Stud. Hist. Phil. Biol. & Biomed. Sci32 (4): 663-87.
384. Riessman, C.K. (2005) ‘Exporting ethics: a narrative about narrative research in South India’, Health9 (4): 473-90.
385. Roco, M.C. and Bainbridge, W.S. (eds) (2003)Converging Technologies for Improving Human Performance: Nanotechnology, Biotechnology, Information Technology and Cognitive Science, Dordrecht: Kluwer.
386. Rose, N. (2001) ‘The politics of life itself’, Theory, Culture and Society18 (6): 1-30.
387. Rose, N. and Novas, C. (2004) ‘Biological citizenship’, in Ong, S. and Collier, S.J. (eds) Global Assemblages: Technology, Politics, and Ethics as Anthropological Problems, Chichester: WileyBlackwell, pp. 439-63.
388. Rose, S (1997)Lifelines: Life Beyond the Gene, Oxford: Oxford University Press.
389. Routledge, P. (1996) ‘The third space as critical engagement’, Antipode28 (4): 399-419.
390. Routledge, P. (2003) ‘Convergence space: process geographies of grassroots globalization networks’, Transactions of the Institute of British Geographers28 (3): 333-49.
391. Royal Society (2003)Keeping science open: the effects of intellectual property policy on the conduct of science, London: Royal Society.
392. Royal Society (2004) Nanoscience and nanotechnologies: opportunities and uncertainties London: Royal Society.
393. SACGT (2001)Development of a Classification Methodology for Genetic Tests, Bethesda: SACGT.
394. Salter, B. and Jones, M. (2002) ‘Regulating human genetics: the changing politics of biotechnology governance in the European Union’, Health, Risk and Society4 (3): 325-40.
395. Saukko, P., Richards, S., Shepherd, M. et al. (2006) ‘Are genetic tests exceptional? Lessons from a qualitative study on thrombophilia’, Social Science & Medicine63 (7): 1947-59.
396. Savage, M. and Burrows, R. (2007) ‘The coming crisis of empirical sociology’, Sociology41 (5): 885-99.
397. Saver, J.L. and Rabin, J. (1997) ‘The neural substrates of religious experience’, Journal of Neuropsychiatry and Clinical Neurosciences (1997) 9: 498-510.
398. Savulescu, J. (2001) ‘Procreative beneficence: why we should select the best children’, Bioethics15: 413-26.
399. Savulescu, J. (2004) ‘Why we are morally obliged to genetically enhance our children’ paper presented at First International Conference on Ethics, Science and Moral Philosophy of Assisted Human Reproduction, Royal Society, London, September 2004.
400. Schmitz, D., Henn, W and Netzer, C. (2009) ‘No risk, no objections? Ethical pitfalls of cell-free fetal DNA and RNA testing’, BMJ339: b2690.
401. Schneider, I. (2007) ‘Indirect commodification of ova donation for assisted reproduction and for human cloning research - proposals for supranational regulation’, in Steinmann, M., Skora, P. and Wiesing, U.(eds) Altruism reconsidered: exploring new approaches to property in human tissue, Aldershot: Ashgate.
402. Schneider, I and Schumann, C. (2002) ‘Stem cells, therapeutic cloning, embryo research-Women as raw material suppliers for science and industry’, in ReproKult, Reproductive Medicine and Genetic Engineering: Women between Self-determination and Societal Standardisation, Cologne: Federal Centre for Health Education.
403. Schramm, K. (2007)Report on Research Stay at the University of Chicago, HalleWittenberg: Martin-Luther-Universität.
404. Schroeder, D. (2007) ‘Benefit sharing: it’s time for a definition’, Journal of Medical Ethics33: 205-9.
405. Science(1998) ‘Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome’, Science280 (5366): 1077-82.
406. Science (2008) ‘Breakthrough of the year: reprogramming cells’, Science322 (5909): 1766-7.
407. Sen, J., Anita Anand, A., Escoba, A. and Waterman, P.(2004)The World Social Forum: Challenging Empires, New Delhi: Viveka Foundation.
408. Sexton, S. (1999)If cloning is the answer, what was the question? Power and decisionmaking in the geneticization of health, Sturminster Newton, Dorset: Corner House.
409. Sexton, S. (2002) ‘Deceptive promises of cures for disease’, World-Watch July 2002.
410. Sexton, S. (2005) ‘Transforming “waste” into “resource”: from women’s eggs to economics for women’, presented at ReproKult workshop ‘Commodification and Commercialisation of Women’s Bodies’ at Femme Globale Conference, 10 September 2005.
411. Shiva, V. (1989)Staying Alive: Women, Ecology and Survival in India, London: Zed Press.
412. Silver, L.M.(1997)Remaking Eden: How Genetic Engineering and Cloning Will Transform the American Family, New York: Harper.
413. SIMR (2005) ‘About SIMR’ http://www.simr.org.uk/ (accessed 1 January 2005)
414. SIMR (now PVMA) content no longer accessible.
415. Skene, L. (2001) ‘Genetic secrets and the family: a response to Bell and Bennett’, Medical Law Review9 (2): 162-9.
416. Snow, D. and Benford, R. (1992) ‘Master frames and cycles of Protest’, in Morris, A.D. and Mueller, C. (eds) Frontiers in Social Movement Theory, New Haven, CT: Yale University Press.
417. Solanas, V. (1968)The SCUM Manifesto (Society For Cutting Up Men), Paris: Olympia Press.
418. SoR (2007) ‘TUC: Society says “Genetic testing by employers and insurance companies must be regulated”’, Society of Radiographers News.
419. Souza, A. (2003) ‘People with Down’s syndrome disrupt screening conference’, Inclusion Now vol. 7.
420. Spallone, P. (1988)Beyond Conception: The New Politics of Reproduction, Basingstoke: Macmillan.
421. Spallone, P. (1992)Generation Games: Genetic Engineering and the Future for Our Lives, London: The Women’s Press.
422. Stafford, M. and Marmot, M. (2003) ‘Neighbourhood deprivation and health: does it affect us all equally?’International Journal of Epidemiology32 (3) 357-66.
423. Stanley, L. (1991) ‘Feminist auto/biography and feminist epistemology?’ in Aaron, J. and Walby, S. (eds) Out of the Margins; Women’s Studies in the Nineties, London: Falmer Press.
424. Star, S.L. and Griesemer, J.R. (1989). ‘Institutional ecology, “translations” and boundary objects: amateurs and professionals in Berkeley’s Museum of Vertebrate Zoology, 1907-39’, Social Studies of Science19 (3): 387-420.
425. Steinberg, M. (1998) ‘Tilting the frame: Considerations on collective action framing from a discursive turn’, Theory and Society27(6): 845-72.
426. Sulston, J. and Ferry, G. (2002)The Common Thread, London: Bantam Press.
427. Sulston, J.E. and Horvitz, H.R. (1977) ‘Post-embryonic cell lineages of the nematode, C. elegans’, Developmental Biology, 56 (1):110-56.
428. Sun(2006) ‘Docs to create mootant cells’, 7 November 2006.
429. Szerszynski, B. (2005) ‘Beating the unbound: political theatre in the laboratory without walls’, in Giannachi, G. and Stewart, N., Performing Nature: Explorations in Ecology and the Arts, Frankfurt: Peter Lang.
430. TAC (2003) ‘Settlement agreements secure access to affordable life-saving antiretroviral medicines’, Treatment Action Campaign Newsletter 10 December.
431. Tait, J. (2001) ‘More Faust than Frankenstein: the European debate about the precautionary principle and risk regulation for genetically modified crops’, Journal of Risk Research4 (2):175-89.
432. Tarrow, S. (1998)Power in Movement: Social Movements, Collective Action, and Politics, Cambridge: Cambridge University Press.
433. Telegraph, The Daily (2006) ‘Volunteers never think it will happen to them’, 16 March 2006, p. 10.
434. Telegraph, The Daily (2008) ‘UK biotech bosses call for Government rescue’, 4 December.
435. The Age(2008) ‘Controversial stem cell treatment draws Australians to Indian clinic’, The Age 2 February.
436. Thomson, J., Itskovitz-Eldor, J., Shapiro, E. (1998). ‘Embryonic stem cell lines derived from human blastocysts’, Science282 (5391): 1145-7.
437. Throsby, K. (2004)When IVF Fails: Feminism, Infertility and the Negotiation of Normality, Basingstoke: Palgrave.
438. Time(2008) ‘Roche’s Rush. How the Swiss firm is redefining the R& D crapshoot in its quest to land the next pharmaceutical breakthrough’, 172 (15).
439. Time (2009) ‘Diabetes, heart disease, Parkinson’s: how the coming revolution in stem cells could save your life’, 9 February.
440. Times, The(2006) ‘Junk medicine: therapeutic cloning - Science must milk the cow’, 11 November.
441. Times, The (2007) ‘Discovery of “deaf gene” raises hopes of treatment’, 18 June.
442. Times, The (2008a) ‘Animal-human embryo research is approved’, 18 January.
443. Times, The (2008b) ‘David Cameron tells the fat and the poor: take responsibility’, 8 July.
444. Times, The (2008c) ‘Postcode lottery of life and death’, 28 August 2008.
445. Times, The (2008d) ‘European ruling could force “innocent” DNA samples to be removed from UK database’, 4 December.
446. Times, The (2008e) ‘A stem bears fruit’, 20 December.
447. Times, The (2009) ‘Parents to be offered test to detect inherited diseases in embryos’, 1 July.
448. Torgersen, H., Jurgen Hampel, J. and von Bergmann-Winberg, M. et al. (2003) ‘Promise, problems and proxies: twenty five years of debate and regulation in Europe’, in Bauer, M.W. and Gaskell, G. (eds) Biotechnology: The making of a global controversy, Cambridge: Cambridge University Press.
449. Tormey, S. (2004)Anticapitalism: A Beginner’s Guide, Oxford: Oneworld.
450. Tutton, R., Kerr, A. and Cunningham-Burley, S. (2005) ‘Myriad stories: constructing expertise and citizenship in discussions of the new genetics’, in Leach, M., Scoones, I. and Wynne, B.(eds) Science and Citizens, London: Zed Books.
451. UCL (ca. 2008) Intercalated BSc Degree in Philosophy, Medicine, and Society, London: University College.
452. UK Biobank (2007a)Ethics and Governance Framework, London: UK Biobank.
453. UK Biobank (2007b) ‘Invite letter’, London: UK Biobank.
454. UKGTN (2008)UK Genetic Testing Network: First Report, London: UKGTN.
455. UKSCB (2004)First Report from the UK Stem Cell Bank, London: UK Stem Cell Bank.
456. UKSCF (2009) ‘Stem cell research benefits and future hopes’, (Brochure) London: UKSCF.
457. UN Wire(2002) ‘NGOs begin meeting in Johannesburg’, 19 August.
458. UNESCO (2002)Human Genetic Data: Preliminary Study by the International Bioethics Committee on its Collection, Processing, Storage and Use, Geneva: UNESCO.
459. UNESCO (2003)International Declaration on Human Genetic Data, Paris: UNESCO.
460. Uusitalo, S. (2008) ‘Affective implications of GM food on social and individual integrity: an ethical approach’, in Molfino, F. and Zucco, F. (eds) Women in Biotechnology: Creating Interfaces, New York: Springer.
461. Venter, J.C. (2007)A Life Decoded. My Genome: My Life, New York: Viking.
462. VHB (2008) ‘Life-saving today. Life-changing tomorrow’, (Brochure) London: Virgin Health Bank.
463. Wailoo, K. and Pemberton, S. (2006)The Troubled Dream of Genetic Medicine: Ethnicity and Innovation in Tay-Sachs, Cystic Fibrosis, and Sickle Cell Disease, Baltimore, MD: Johns Hopkins University Press.
464. Waldby, C. (2002) ‘Stem cells, tissue cultures and the production of biovalue’, Journal for the Social Study of Health, Illness and Medicine6 (3): 305-23.
465. Wallace, H.M. (2006) ‘A model of gene-gene and gene-environment interactions and its implications for targeting environmental interventions by genotype’, Theoretical Biology and Medical Modelling (2006) 3: 35.
466. Wallace, H.M. (2008a) House of Lords Select Committee on Science and Technology, Hansard 9 July p. 8.
467. Wallace, H.M. (2008b) ‘Most gene test sales are misleading’, Nature Biotechnology, 26: 1221.
468. Warnock (1984)Report of the Committee of Inquiry into Human Fertilisation and Embryology (the Warnock Report), Cmd 9314, London: HMSO.
469. Watson, J.D. and Crick, F.H.C. (1953) ‘A Structure for Deoxyribose Nucleic Acid’, Nature171 (4356): 737.
470. Wellcome (2004)UK Biobank Ethics and Governance Framework, London: Wellcome Foundation.
471. Welsh, I. (2000)Mobilising Modernity: the Nuclear Moment, London: Routledge.
472. Welsh, I., Plows, A. and Evans, R. (2007) ‘Human rights and genomics: science, genomics and social movements at the 2004 London Social Forum’, New Genetics and Society26 (2): 123-35.
473. WHO (1946)Constitution of the World Health Organization, New York: World Health Organization.
474. WHO (2002)Human Genetic Technologies: Implications for Preventive Health Care, Geneva: World Health Organization.
475. WHO (2004)Priorities for Research to Take Forward the Health Equity Policy Agenda, Geneva: WHO.
476. WHO (2005)Genetics, genomics and the patenting of DNA: Review of potential implications for health in developing countries, Geneva: WHO.
477. Wikipedia (2009a) DNA Sequencing http://en.wikipedia.org/wiki/DNA_sequencing (accessed 8 June 2009).
478. Wikipedia (2009b) Diamond v. Chakrabarty, 447 U.S. 303 (1980), a United States Supreme Court case dealing with whether genetically modified micro-organisms can be patented http://en.wikipedia.org/wiki/Diamond_v._Chakrabarty (accessed 9 June 2009).
479. Wilkinson, R.G (1996)Unhealthy Societies: The Afflictions of Inequality, London: Routledge.
480. Wilkinson, S. (2008) ‘Sexism, sex selection and “family balancing”’, Medical Law Review16 (3): 369-89.
481. Wilsdon, J. and Willis, R. (eds) (2004)See-through science; why public engagement needs to move ‘upstream’, London: Demos.
482. Wilsden, J. and Miller, P. (2006)Better Humans, London: Demos.
483. Wilson, E.O. (2000)Sociobiology: The New Synthesis, Cambridge, MA: Harvard University Press.
484. WIPO (2006) ‘Bioethics and patent law: the case of myriad’, WIPO Magazine.
485. WMA (2008)Declaration of Helsinki, Helsinki: World Medical Association.
486. Wolbring, G. (2006) ‘The unenhanced underclass’, in Miller, P. and Wilsdon, J. (eds). Better Humans? The politics of human enhancement and life extension, London: Demos.
487. Woyke, A. (2008) ‘The world view of nanotechnology - philosophical reflections’, in Jotterand, F. (ed.)Emerging Conceptual, Ethical and Policy Issues in Bionanotechnology, New York: Springer.
488. Wynne, B. (1996) ‘May the sheep safely graze? A reflexive view of the expert-lay knowledge divide’, in Lash, S., Szerszynski, B. and Wynne, B. (eds) Risk, Environment & Modernity: Towards a New Ecology, London: Sage.
489. Wynne, B. (2006) ‘Public engagement as a means of restoring public trust in science – hitting the notes, but missing the music?’Community Genetics2006 (9): 211-20.
490. Yeo, R. (2007)‘I don’t have a problem, the problem is theirs’: the priorities of Bolivian disabled people, Leeds: Disability Press.